Art. -Nr.: HY-15475

UK-5099

(Synonyms: PF-1005023)

56 Cited Publications

Kundenbewertung

Based on 56 publication(s) in Google Scholar

UK-5099 (PF-1005023) is a potent inhibitor of the mitochondrial pyruvate carrier (MPC). UK-5099 (PF-1005023) inhibits pyruvate-dependent O₂ consumption with an IC₅₀ of 50 nM.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

Reinheit: 99.95%
CAS. Nr.: 56396-35-1
Formel: C₁₈H₁₂N₂O₂
Molecular Weight:288.30

Speicherung:

Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month

UK-5099 Chemical Structure

CAS. Nr.: 56396-35-1

Größe

Preis

Verfügbarkeit

Menge

Sample (0.1mg)

In-stock

(In Japan)

Apply Now

Angebot einholen Ask For Quote & Lead Time Consult sales personnel for more information Check price and availability Angebot einholen Ask For Quote & Lead Time Consult sales personnel for more information Check price and availability

Massenanfrage

Amount: USD 0.00

* Bitte wählen Sie Menge, bevor Sie Artikel hinzufügen.

Top Publications Citing

Use of MCE Products

Fluorescent Dye

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Biologische Aktivität
- Beschreibung
- IC₅₀ & Target
- In Vitro
- In Vivo
Chemical Information
Publications (56)
Lösungsmittel & Löslichkeit
- In Vitro
- In Vivo
Protokoll
Reinheit & Dokumentation
Verweise
Help & FAQs
Bioz

Biologische Aktivität

Beschreibung

UK-5099 (PF-1005023) is a potent inhibitor of the mitochondrial pyruvate carrier (MPC). UK-5099 (PF-1005023) inhibits pyruvate-dependent O₂ consumption with an IC₅₀ of 50 nM.

IC₅₀ & Target

IC50: 50 nM (MPC)^[1]

In Vitro

The trypanosomal pyruvate carrier is found to be rather insensitive to inhibition by alpha-cyano-4-hydroxycinnamate (K_i=17 mM) but can be completely blocked by UK-5099 (K_i=49 microM)^[2]. UK-5099 also inhibits the monocarboxylate transporter (MCT) ^[3]. UK5099 significantly inhibits the glucose-stimulated rise in oxygen consumption in a dose-dependent manner and at 150 μM reduced oxygen consumption below basal levels. UK5099 reduces ATP levels and increases ADP and AMP levels in 832/13 cells^[4]. The UK5099 treated cells show significantly higher proportion of side population fraction and express higher levels of stemness markers Oct3/4 and Nanog. UK5099 application may be an ideal model for Warburg effect studies^[5].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

In Vivo

The MPC inhibitor UK5099 increases the glucose excursion seen during an intraperitoneal glucose tolerance test in C57BLK mice^[4].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Chemical Information

CAS. Nr. 56396-35-1
Appearance Solid
Molecular Weight 288.30
Formel C₁₈H₁₂N₂O₂
Color Light yellow to yellow
SMILES

O=C(O)/C(C#N)=C/C1=CN(C2=CC=CC=C2)C3=C1C=CC=C3
Synonyms

PF-1005023
Versand

Room temperature in continental US; may vary elsewhere.

Speicherung

Powder	-20°C	3 years
	4°C	2 years
In solvent	-80°C	6 months
	-20°C	1 month

Publications (56)

All Cell Proliferation/Viability AssayFlow CytometryWB

Sort by:

Journal Impact Factor

Cell Metab

Tumor-associated macrophages are shaped by intratumoral high potassium via Kir2.1. [Abstract]

2022 Nov 1;34(11):1843-1859.e11. PMID: 36103895
Nat Immunol

Influenza-trained mucosal-resident alveolar macrophages confer long-term antitumor immunity in the lungs. [Abstract]

2023 Mar;24(3):423-438. PMID: 36807642
Immunity

A type I interferon-mitochondrial axis regulates efferocytosis and interferon-stimulated gene induction in macrophages. [Abstract]

2026 Jan 28:S1074-7613(25)00566-7. PMID: 41610845
Mol Cell

Functional nutrient-genetic profiling reveals biotin and FBXW7 are essential to bypass glutamine addiction. [Abstract]

2026 Feb 25:S1097-2765(26)00097-3. PMID: 41747732
Mol Cell

pLxIS-containing domains are biochemically flexible regulators of interferons and metabolism. [Abstract]

2024 Jun 21:S1097-2765(24)00477-5. PMID: 38925114
Nat Commun

TIGIT deficiency promotes autoreactive CD4+ T-cell responses through a metabolic‒epigenetic mechanism in autoimmune myositis. [Abstract]

2025 May 15;16(1):4502. PMID: 40374622

UK-5099 purchased from MedChemExpress. Usage Cited in: Nat Commun. 2025 May 15;16(1):4502. [Abstract]

Naive Tigit−/− or Tigit+/+ CD4+ T cells were cultured under Th1- or Th17- polarizing condition for 5 d. UK5099 (20 μM), MSDC-0602 (10 μM), Etomoxir (ETO, 1 μM), or bis-2-(5-phenylacetamido-1, 2, 4-thiadiazol-2-yl) ethyl sulfide (BPTES, 3 μM) was included for the last 48 h of culture. IFNγ, T-bet, IL-17A, and RORγt expression in CD4+ T cells were measured by flow cytometry.

UK-5099 purchased from MedChemExpress. Usage Cited in: Nat Commun. 2025 May 15;16(1):4502. [Abstract]

Naive Tigit−/− or Tigit+/+ CD4+ T cells were cultured under Th1- or Th17- polarizing condition for 5 d. UK5099 (20 μM), MSDC-0602 (10 μM), Etomoxir (ETO,1 μM), or bis-2-(5-phenylacetamido-1, 2,4-thiadiazol-2-yl) ethyl sulfide (BPTES, 3 μM) was included for the last 48 h of culture. IFNγ, T-bet, IL-17A, and RORγt expression in CD4+ T cells were measured by flow cytometry.

UK-5099 purchased from MedChemExpress. Usage Cited in: Nat Commun. 2025 May 15;16(1):4502. [Abstract]

CD4+ T cells from HC or PM patients were stimulated with αCD3/CD28 in the presence of UK5099 (20 μM), recombinant human CD155-Fc (10 μg/ml), or control IgG1 for 3 d.

UK-5099 purchased from MedChemExpress. Usage Cited in: Nat Commun. 2025 May 15;16(1):4502. [Abstract]

Immunoblot analysis of acetylated H3K9 and H3K27 in mouse CD4+ T cells and representative bands.Cells were stimulated with αCD3/CD28 for 3 days in the presence of UK5099 (20 μM), ETO, or BPTES.
Nat Commun

Targeting fatty acid oxidation enhances response to HER2-targeted therapy. [Abstract]

2024 Aug 3;15(1):6587. PMID: 39097623

UK-5099 purchased from MedChemExpress. Usage Cited in: Nat Commun. 2024 Aug 3;15(1):6587. [Abstract]

NIC cells were treated with 10μM UK5099, or DMSO as a control. Proliferation was assessed by Incucyte® to measure cell confluency in real time.
Nat Commun

Lactate-dependent transcriptional regulation controls mammalian eye morphogenesis. [Abstract]

2023 Jul 14;14(1):4129. PMID: 37452018
Theranostics

STIM1 is a metabolic checkpoint regulating the invasion and metastasis of hepatocellular carcinoma. [Abstract]

2020 May 16;10(14):6483-6499. PMID: 32483465
Small

Dynamically Reprograms Mitochondrial Respiration to Augment Cuproptosis in Cancer Therapy. [Abstract]

2026 Mar;22(18):e13435. PMID: 41653427
Redox Biol

Hypobaric hypoxia-driven energy metabolism disturbance facilitates vascular endothelial dysfunction. [Abstract]

2025 May 17:84:103675. PMID: 40393151
Redox Biol

Enteric coronavirus PDCoV evokes a non-Warburg effect by hijacking pyruvic acid as a metabolic hub. [Abstract]

2024 May:71:103112. PMID: 38461791
Brain

Dysregulation of muscle cholesterol transport in amyotrophic lateral sclerosis. [Abstract]

2024 Aug 28:awae270. PMID: 39197036
Engineering

2024 Sep 6.
ACS Cent Sci

High-Performance Genetically Encoded Green Fluorescent Biosensors for Intracellular l-Lactate. [Abstract]

2024 Jan 31;10(2):402-416. PMID: 38435524
Acta Biomater

A tumor microenvironment-responsive nanocomposite for enhanced copper retention and hypoxia reversal to promote cuproptosis in tumor treatment. [Abstract]

2025 Aug:202:463-475. PMID: 40618974
Proc Natl Acad Sci U S A

Ace2 safeguards embryonic hematopoietic stem and progenitor cell production by restraining Nlrp3-mediated pyroptosis. [Abstract]

2025 Dec 9;122(49):e2515641122. PMID: 41348733
ACS Appl Mater Interfaces

Bioresponsive Nanoparticles Boost Starvation Therapy and Prevent Premetastatic Niche Formation for Pulmonary Metastasis Treatment. [Abstract]

2024 Oct 2;16(39):51798-51806. PMID: 39301793
Environ Pollut

Effects of polystyrene microparticles exposures on spermatogenic cell differentiation and reproductive endpoints in male mice. [Abstract]

2025 Apr 3:373:126200. PMID: 40185193
PLoS Biol

The cell cycle regulator PLK1 promotes murine melanoma progression by regulating the transcription factor BACH1. [Abstract]

2025 Nov 24;23(11):e3003490. PMID: 41284701
Cell Rep

Nucleo-cytosolic acetyl-CoA drives tumor immune evasion by regulating PD-L1 in melanoma. [Abstract]

2024 Nov 26;43(12):115015. PMID: 39602308
Cell Rep

Cancer cells reprogram to metastatic state through the acquisition of platelet mitochondria. [Abstract]

2023 Sep 26;42(9):113147. PMID: 37756158
Cell Rep

Aberrant metabolite trafficking and fuel sensitivity in human pluripotent stem cell-derived islets. [Abstract]

2023 Aug 8;42(8):112970. PMID: 37556323
Cell Rep

Pyruvate metabolism controls chromatin remodeling during CD4+ T cell activation. [Abstract]

2023 Jun 1;42(6):112583. PMID: 37267106
Cell Rep

Diurnal regulation of oxidative phosphorylation restricts hepatocyte proliferation and inflammation. [Abstract]

2021 Sep 7;36(10):109659. PMID: 34496251
Mol Metab

Glucose-1,6-bisphosphate: A new gatekeeper of cerebral mitochondrial pyruvate uptake. [Abstract]

2024 Aug 23:102018. PMID: 39182844
Mol Metab

Reprogramming hormone-sensitive prostate cancer to a lethal neuroendocrine cancer lineage by mitochondrial pyruvate carrier (MPC). [Abstract]

2022 May:59:101466. PMID: 35219875
Int J Nanomedicine

Tumor Microenvironment Reprogramming via Copper-Enriched Black Phosphorus Nanoplatform for Cuproptosis-Sensitized Low-Dose Radioimmunotherapy. [Abstract]

2025 Dec 5:20:14551-14569. PMID: 41383282
J Cell Biol

Irg1l regulates neuromast size via metabolic reprogramming to promote supporting cell proliferation. [Abstract]

2025 Dec 1;224(12):e202501122. PMID: 41147954
Fundam Res

Astrocytic pyruvate dehydrogenase kinase-lactic acid axis involvement in glia-neuron crosstalk contributes to morphine-induced hyperalgesia in mice. [Abstract]

2023 Mar 6;4(4):820-828. PMID: 39161415
J Agric Food Chem

Elevated PINK1/Parkin-Dependent Mitophagy and Boosted Mitochondrial Function Mediate Protection of HepG2 Cells from Excess Palmitic Acid by Hesperetin. [Abstract]

2024 Jun 12;72(23):13039-13053. PMID: 38809522
Geroscience

Cell-free ascites from ovarian cancer patients induces Warburg metabolism and cell proliferation through TGFβ-ERK signaling. [Abstract]

2024 Aug;46(4):3581-3597. PMID: 38196068
Cancer Metab

Unveiling the powerhouse: ASCL1-driven small cell lung cancer is characterized by higher numbers of mitochondria and enhanced oxidative phosphorylation. [Abstract]

2025 Mar 31;13(1):16. PMID: 40165271
J Pathol

Lactate-mediated activation of GPR81 regulates BCR/Abl protein expression in chronic myeloid leukemia cells selected under low oxygen tension. [Abstract]

2025 Oct 23. PMID: 41128634
Glia

Drosophila tweety facilitates autophagy to regulate mitochondrial homeostasis and bioenergetics in Glia. [Abstract]

2024 Feb;72(2):433-451. PMID: 37870193
iScience

Lactate facilitates classical swine fever virus replication by enhancing cholesterol biosynthesis. [Abstract]

2022 Oct 13;25(11):105353. PMID: 36339254
Oncol Res

Lactate Maintains BCR/Abl Expression and Signaling in Chronic Myeloid Leukemia Cells Under Nutrient Restriction. [Abstract]

2022 May 4;29(1):33-46. PMID: 35131002
iScience

Excipient of paclitaxel induces metabolic dysregulation and unfolded protein response. [Abstract]

2021 Sep 25;24(10):103170. PMID: 34646996
Virol Sin

Thapsigargin suppresses porcine hemagglutinating encephalomyelitis virus replication by disrupting host energy metabolism. [Abstract]

2025 Nov 21:S1995-820X(25)00161-0. PMID: 41276220
J Biol Chem

Mitochondrial pyruvate carrier blockade results in decreased osteoclastogenesis and bone resorption via regulating mitochondrial energy production. [Abstract]

2022 Mar 4:101775. PMID: 35257748
Neurophotonics

Two-point calibration protocol for the Förster Resonance Energy Transfer indicator Pyronic in neurons. [Abstract]

2025 Jun;12(Suppl 2):S22807. PMID: 41141230
J Virol

African Swine Fever Virus Regulates Host Energy and Amino Acid Metabolism To Promote Viral Replication. [Abstract]

2022 Feb 23;96(4):e0191921. PMID: 34908441
Eur J Immunol

Hyperinflammation by Human Macrophages Induced by SARS-CoV-2 Anti-Spike IgG Is Dependent on Glucose and Fatty Acid Metabolism. [Abstract]

2025 Dec;55(12):e70087. PMID: 41416928
Eur J Immunol

Dysfunction of S100A4+ effector memory CD8+ T cells aggravates asthma. [Abstract]

2022 Jun;52(6):978-993. PMID: 35340022
Exp Cell Res

p38 MAPK-mediated suppression of Nrf2-MPC2 axis drives metabolic reprogramming which confers imatinib resistance in blast crisis phase of chronic myeloid leukemia. [Abstract]

2025 Dec 19;455(2):114870. PMID: 41423144
Free Radic Res

Dioscin induces ferroptosis to suppress the metastasis of gastric cancer through the SLC7A11/GPX4 axis. [Abstract]

2025 Jun 3:1-18. PMID: 40460255
Vet Microbiol

Porcine reproductive and respiratory syndrome virus infection manipulates central carbon metabolism. [Abstract]

2023 Apr:279:109674. PMID: 36739813
J Bone Miner Metab

Extracellular ATP-induced calcium oscillations regulating the differentiation of osteoblasts through aerobic oxidation metabolism pathways. [Abstract]

2023 Sep;41(5):606-620. PMID: 37418073
bioRxiv

Citrate Compartmentalization Controls Calcium-Dependent Cytokine Production in Effector T Cells. [Abstract]

2026 Jun 12:2026.06.11.731694. PMID: 42327233
bioRxiv

2026 Jun 11.
bioRxiv

2026 Apr 20.
bioRxiv

2025 Jun 24.
bioRxiv

2024 August 17.
Research Square Preprint

2023 Sep 15.
Research Square Preprint

2022.
Research Square Print

2022 May.

Lösungsmittel & Löslichkeit

In Vitro:

DMSO : ≥ 50 mg/mL (173.43 mM; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

* "≥" means soluble, but saturation unknown.

View the Complete Stock Solution Preparation Table

Preparing Stock Solutions

View the Complete Stock Solution Preparation Table

Concentration Solvent Mass

1 mg

5 mg

10 mg

Concentration

Solvent

Mass

1 mM

3.4686 mL

17.3430 mL

34.6861 mL

5 mM

0.6937 mL

3.4686 mL

6.9372 mL

10 mM

0.3469 mL

1.7343 mL

3.4686 mL

Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.

Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Molaritätsrechner

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Konzentration Konzentration

Volumen Volumen

Molecular Weight Molecular Weight

Verdünnungsrechner

Konzentration _{(Stammlösung)} × Volumen _{(Stammlösung)} = Konzentration _{(Ziellösung)} × Volumen _{(Ziellösung)}

Konzentration _{(Stammlösung)} Konzentration _{(Stammlösung)}

Volumen _{(Stammlösung)} Volumen _{(Stammlösung)}

Konzentration _{(Ziellösung)} Konzentration _{(Ziellösung)}

Volumen _{(Ziellösung)} Volumen _{(Ziellösung)}

In Vivo:

Select the appropriate dissolution method based on your experimental animal and administration route.

Stock Solution Working Solution

For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

Protocol 1

Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline

Solubility: ≥ 2.5 mg/mL (8.67 mM); Clear solution

This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).

Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.

Protocol 2

Add each solvent one by one: 10% DMSO 90% Corn Oil

Solubility: ≥ 2.5 mg/mL (8.67 mM); Clear solution

This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown). If the continuous dosing period exceeds half a month, please choose this protocol carefully.

Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL Corn oil, and mix evenly.

In Vivo Dissolution Calculator

Please enter the basic information of animal experiments:

Dosage Dosage
mg/kg
Animal Weight (Per Animal) Animal Weight (Per Animal)
g
Dosing Volume (Per Animal) Dosing Volume (Per Animal)
μL
Number of Animals Number of Animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.

Please enter your animal formula composition:

%
DMSO +

Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
%
+
+
%
Tween-80 + +
%
Saline +

The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).

Working solution concentration: 0.22 mg/mL

Protokoll

Cell Assay^[4]

The 832/13 cell line is used for experiments. Cell viability is measured using CellTiter Blue. The assay is based on cellular reduction of resazurin to resorufin. Appearance of resorufin is monitored by fluorescence emission at 585 nm using a Spectramax M5 microplate reader with excitation at 555 nm. For UK5099-treated cells, cells are allowed to recover for 1 h before measuring cell viability. Data are expressed as -fold relative to no treatment or siCtrl^[4].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Administration^[4]

C57BLK mice are fasted for 16 h prior to glucose challenge. UK5099 (32 μmol/kg of body weight) or DMSO in PBS is injected into the intraperitoneal cavity 30 min before injecting glucose (1.5 mg of glucose/g of body weight). Blood glucose levels are measured at 0, 10, 20, 30, 60, and 120 min after glucose injection^[4].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Reinheit & Dokumentation

Select Batch:

Reinheit: 99.98%

Assay: 99.98%

ee.: 99.98%

Data Sheet (285 KB)
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Portuguese - PT (393 KB)
COA (2659 KB)
Elemental Analysis Report (2659 KB)
HNMR (2659 KB)
CNMR (2659 KB)
RP-HPLC (2659 KB)
NP-HPLC (2659 KB)
MS (2659 KB)
LCMS (2659 KB)
IR (2659 KB)
GC (2659 KB)
OR (2659 KB)
SDS-PAGE (2659 KB)
SEC-HPLC (2659 KB)
Other Report (2659 KB)
Handling Instructions (2659 KB)

Verweise

[1]. Halestrap AP. The mitochondrial pyruvate carrier. Kinetics and specificity for substrates and inhibitors. Biochem J. 1975 April; 148(1): 85-96. [Content Brief]

[2]. Wiemer EA, et al. The inhibition of pyruvate transport across the plasma membrane of the bloodstream form of Trypanosoma brucei and its metabolic implications. Biochem J. 1995 Dec 1;312 ( Pt 2):479-84. [Content Brief]

[3]. Hinoi E, et al. A molecular mechanism of pyruvate protection against cytotoxicity of reactive oxygen species in osteoblasts. Mol Pharmacol. 2006 Sep;70(3):925-35. Epub 2006 Jun 9. [Content Brief]

[4]. Patterson JN, et al. Mitochondrial metabolism of pyruvate is essential for regulating glucose-stimulated secretion. J Biol Chem. 2014 May 9;289(19):13335-46. [Content Brief]

[5]. Zhong Y, et al. Application of mitochondrial pyruvate carrier blocker UK5099 creates metabolic reprogram and greater stem-like properties in LnCap prostate cancer cells in vitro. Oncotarget. 2015 Nov 10;6(35):37758-69. [Content Brief]

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Complete Stock Solution Preparation Table

Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Optional Solvent	Concentration Solvent Mass	1 mg	5 mg	10 mg	25 mg
DMSO	1 mM	3.4686 mL	17.3430 mL	34.6861 mL	86.7152 mL
	5 mM	0.6937 mL	3.4686 mL	6.9372 mL	17.3430 mL
	10 mM	0.3469 mL	1.7343 mL	3.4686 mL	8.6715 mL
	15 mM	0.2312 mL	1.1562 mL	2.3124 mL	5.7810 mL
	20 mM	0.1734 mL	0.8672 mL	1.7343 mL	4.3358 mL
	25 mM	0.1387 mL	0.6937 mL	1.3874 mL	3.4686 mL
	30 mM	0.1156 mL	0.5781 mL	1.1562 mL	2.8905 mL
	40 mM	0.0867 mL	0.4336 mL	0.8672 mL	2.1679 mL
	50 mM	0.0694 mL	0.3469 mL	0.6937 mL	1.7343 mL
	60 mM	0.0578 mL	0.2891 mL	0.5781 mL	1.4453 mL
	80 mM	0.0434 mL	0.2168 mL	0.4336 mL	1.0839 mL
	100 mM	0.0347 mL	0.1734 mL	0.3469 mL	0.8672 mL

Keywords

UK-5099

56 Cited Publications

100 mg Angebot einholen

Subscribe to the

MedChemExpress

Newsletter

Produktname:
Art. -Nr.:
Menge:
MCE Japan Authorized Agent:

Produktname:
CAS. Nr.:
Species:
Reinheit:
Menge:

UK-5099

Metabolism/Protease Compound Library

Stem Cell Signaling Compound Library

Anti-Cancer Compound Library

Anti-Aging Compound Library

Reprogramming Compound Library

Anti-diabetic Compound Library

Glutamine Metabolism Compound Library

Anti-Cancer Metabolism Compound Library

Anti-Parkinson's Disease Compound Library

Neurodegenerative Disease-related Compound Library

Mitochondria-Targeted Compound Library

Glucose Metabolism Compound Library

Cuproptosis Compound Library

Cancer Stem Cells Compound Library

Mitochondrial Protection Compound Library

Metabolic Enzyme Compound Library

Cysteine Targeted Covalent Library

Mitochondrial Toxicity Compound Library

Bioactive Compound Library Max

Anti-Aging Compound Library Mini

MCE Bioactive Compound Library

Bioactive Compound Library

Non-Alcoholic Fatty Liver Disease (NAFLD) Compound Library

High-Throughput Bioactive Compound Library

Publications Citing Use of MedChemExpress (MCE) UK-5099

Biologische Aktivität

Chemical Information

Publications (56)

Lösungsmittel & Löslichkeit

Protokoll

Reinheit & Dokumentation

Verweise

Help & FAQs

Complete Stock Solution Preparation Table

UK-5099

Metabolism/Protease Compound Library

Stem Cell Signaling Compound Library

Anti-Cancer Compound Library

Anti-Aging Compound Library

Reprogramming Compound Library

Anti-diabetic Compound Library

Glutamine Metabolism Compound Library

Anti-Cancer Metabolism Compound Library

Anti-Parkinson's Disease Compound Library

Neurodegenerative Disease-related Compound Library

Mitochondria-Targeted Compound Library

Glucose Metabolism Compound Library

Cuproptosis Compound Library

Cancer Stem Cells Compound Library

Mitochondrial Protection Compound Library

Metabolic Enzyme Compound Library

Cysteine Targeted Covalent Library

Mitochondrial Toxicity Compound Library

Bioactive Compound Library Max

Anti-Aging Compound Library Mini

MCE Bioactive Compound Library

Bioactive Compound Library

Non-Alcoholic Fatty Liver Disease (NAFLD) Compound Library

High-Throughput Bioactive Compound Library

Publications Citing Use of MedChemExpress (MCE) UK-5099

Biologische Aktivität

Chemical Information

Publications (56)

Lösungsmittel & Löslichkeit

Protokoll

Reinheit & Dokumentation

Verweise

Help & FAQs

Complete Stock Solution Preparation Table

UK-5099 Related Classifications

Art. -Nr.: HY-15475